These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20356072)

  • 21. Modeling phospholipidosis induction: reliability and warnings.
    Goracci L; Ceccarelli M; Bonelli D; Cruciani G
    J Chem Inf Model; 2013 Jun; 53(6):1436-46. PubMed ID: 23692521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potential.
    Pelletier DJ; Gehlhaar D; Tilloy-Ellul A; Johnson TO; Greene N
    J Chem Inf Model; 2007; 47(3):1196-205. PubMed ID: 17428028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes.
    Ikeda K; Hirayama M; Hirota Y; Asa E; Seki J; Tanaka Y
    Biochem Biophys Res Commun; 2008 Dec; 377(1):268-74. PubMed ID: 18840403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why are most phospholipidosis inducers also hERG blockers?
    Slavov S; Stoyanova-Slavova I; Li S; Zhao J; Huang R; Xia M; Beger R
    Arch Toxicol; 2017 Dec; 91(12):3885-3895. PubMed ID: 28551711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative Assessment of Drug Delivery to Tissues and Association with Phospholipidosis: A Case Study with Two Structurally Related Diamines in Development.
    Loryan I; Hoppe E; Hansen K; Held F; Kless A; Linz K; Marossek V; Nolte B; Ratcliffe P; Saunders D; Terlinden R; Wegert A; Welbers A; Will O; Hammarlund-Udenaes M
    Mol Pharm; 2017 Dec; 14(12):4362-4373. PubMed ID: 29099189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposome electrokinetic chromatography based in vitro model for early screening of the drug-induced phospholipidosis risk.
    Wang T; Feng Y; Jin X; Fan X; Crommen J; Jiang Z
    J Pharm Biomed Anal; 2014 Aug; 96():263-71. PubMed ID: 24814828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines.
    Ploemen JP; Kelder J; Hafmans T; van de Sandt H; van Burgsteden JA; Saleminki PJ; van Esch E
    Exp Toxicol Pathol; 2004 Mar; 55(5):347-55. PubMed ID: 15088636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physicochemical and cell-based approach for early screening of phospholipidosis-inducing potential.
    Tomizawa K; Sugano K; Yamada H; Horii I
    J Toxicol Sci; 2006 Oct; 31(4):315-24. PubMed ID: 17077586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bis(monoacylglycerol)phosphate as a non-invasive biomarker to monitor the onset and time-course of phospholipidosis with drug-induced toxicities.
    Tengstrand EA; Miwa GT; Hsieh FY
    Expert Opin Drug Metab Toxicol; 2010 May; 6(5):555-70. PubMed ID: 20370598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico modeling to predict drug-induced phospholipidosis.
    Choi SS; Kim JS; Valerio LG; Sadrieh N
    Toxicol Appl Pharmacol; 2013 Jun; 269(2):195-204. PubMed ID: 23541745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of drugs inducing phospholipidosis by novel in vitro data.
    Muehlbacher M; Tripal P; Roas F; Kornhuber J
    ChemMedChem; 2012 Nov; 7(11):1925-34. PubMed ID: 22945602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How does the quality of phospholipidosis data influence the predictivity of structural alerts?
    Przybylak KR; Alzahrani AR; Cronin MT
    J Chem Inf Model; 2014 Aug; 54(8):2224-32. PubMed ID: 25062434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phospholipidosis assay in HepG2 cells and rat or rhesus hepatocytes using phospholipid probe NBD-PE.
    Bhandari N; Figueroa DJ; Lawrence JW; Gerhold DL
    Assay Drug Dev Technol; 2008 Jun; 6(3):407-19. PubMed ID: 18537465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are hERG channel blockers also phospholipidosis inducers?
    Sun H; Xia M; Shahane SA; Jadhav A; Austin CP; Huang R
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4587-90. PubMed ID: 23856051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of an in vitro high-throughput screening assay for detecting phospholipidosis-inducing potential.
    Kasahara T; Tomita K; Murano H; Harada T; Tsubakimoto K; Ogihara T; Ohnishi S; Kakinuma C
    Toxicol Sci; 2006 Mar; 90(1):133-41. PubMed ID: 16338956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phospholipidosis effect of drugs by adsorption into lipid monolayers.
    Ceccarelli M; Germani R; Massari S; Petit C; Nurisso A; Wolfender JL; Goracci L
    Colloids Surf B Biointerfaces; 2015 Dec; 136():175-84. PubMed ID: 26387069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. pH-gradient PAMPA-based in vitro model assay for drug-induced phospholipidosis in early stage of drug discovery.
    Balogh GT; Müller J; Könczöl A
    Eur J Pharm Sci; 2013 Apr; 49(1):81-9. PubMed ID: 23439241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a novel set of biomarkers for evaluating phospholipidosis-inducing potential of compounds using rat liver microarray data measured 24-h after single dose administration.
    Yudate HT; Kai T; Aoki M; Minowa Y; Yamada T; Kimura T; Ono A; Yamada H; Ohno Y; Urushidani T
    Toxicology; 2012 May; 295(1-3):1-7. PubMed ID: 22426296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cell-based assay using HepaRG cells for predicting drug-induced phospholipidosis.
    Tomida T; Ishimura M; Iwaki M
    J Toxicol Sci; 2017; 42(5):641-650. PubMed ID: 28904299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrophilic interaction chromatography with a focus on the drug-phosphate interaction in drug screening to determine the phospholipidosis induction risk.
    Okamoto H; Hamaguchi R; Kuroda Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Apr; 1051():33-40. PubMed ID: 28285021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.